amgen profit - Search News

News

Amgen, Q2

Amgen inches lower premarket despite second-quarter earnings beat

Amgen Inc (NASDAQ:AMGN) shares were slightly lower in premarket trading despite posting better-than-expected quarterly profit and revenue, with strong product growth across both legacy franchises and newer assets.

InvestorsHub on MSN · 9h

Amgen shares dip slightly in early trading despite beating Q2 earnings forecasts

Amgen Inc (NASDAQ:AMGN) saw a modest decline in premarket trading even after reporting quarterly profit and revenue results that exceeded analysts’ expectations, driven by robust growth in both established and newer product lines.

Seeking Alpha on MSN · 21h

Amgen beat Q2 revenue and profit, stock trades flat

Amgen (NASDAQ:AMGN) surpasses Q2 earnings and revenue expectations with a 9.4% revenue growth. Read more here.

20hon MSN

Amgen profit rises, weight-loss data expected in 4th quarter

Amgen on Tuesday posted quarterly financial results that beat Wall Street expectations as a 9% increase in product sales ...

22hon MSN

Amgen Posts Higher Profit, Revenue On Sales Growth Among Products

Fifteen of the biotechnology company’s products delivered at least double-digit sales growth in the second quarter.

14h

Amgen (AMGN) Q2 Profit Jumps 21%

Non-GAAP earnings per share for Q2 2025 beat estimates by 14.0%, rising to $6.02 (non-GAAP) and up 21% year over year (non-GAAP). Revenue increased 9% to $9.2 billion, exceeding analyst expectations ...

Uncovering Potential: Amgen's Earnings Preview

Analysts estimate that Amgen will report an earnings per share (EPS) of $5.26. The announcement from Amgen is eagerly anticipated, with investors seeking news of surpassing estimates and favorable ...

20h

Stocks to Watch Afterhours: AMD, Amgen, Snap

The stock slipped 3.5% postmarket after the chip maker reported adjusted earnings per share in line with estimates.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results